TNXP

Tonix Pharmaceuticals Holding Corp. is a biotechnology company focused on developing therapies for complex, chronic conditions, including nociplastic pain, immunology, and infectious diseases. Its product pipeline includes TNX-102 SL for acute stress disorder and multi-site pain associated with Long COVID, as well as TNX-8012, a live horsepox virus vaccine for smallpox and mpox. The company also develops TNX-1500, an anti-CD40L monoclonal antibody for autoimmune conditions, and TNX-2900 for Prader-Willi syndrome. Tonix operates primarily in the United States.